Cancer Therapy Research Center

San Antonio, Texas 78229-4427

0 studies enrolling now · 15 studies all time

What they study most

Advanced Solid Tumors, B-cell Lymphoma, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Hodgkin's Lymphoma, Liver Cancer, Lung Cancer, Lymphoma, B-Cell, Malignant Pleural Mesothelioma, Neoplasm Metastasis, Non-Hodgkin's Lymphoma

Studies at this site

• A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies — Running, not enrolling
• Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma — Stopped early
• Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) — Completed
• A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer — Stopped early
• Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies — Completed
• Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors — Completed
• A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) — Completed
• A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma — Stopped early
• Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer — Stopped early
• Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer — Completed
• Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma — Stopped early
• Bizelesin in Treating Patients With Advanced Cancer — Completed
• DX-8951f in Treating Patients With Liver Cancer — Completed
• DX-8951f in Treating Patients With Biliary Cancer — Completed
• Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor — Stopped early